Basophils: Diagnostic Significance and Clinical Insights

Authors: Payal Bhandari, M.D., Emilia Feria, Madison Granados

Contributors: Vivi Chador, Hailey Chin 




Basophils


Basophils fight infections, prevent clotting, and mediate allergies. Produced in bone marrow, they reside in various tissues. Abnormal levels may signal thyroid, bone marrow, or digestive dysfunction linked to autoimmune or allergic reactions.




Typical Adult Range

Ranges and thresholds can vary due to: 

(1) Lab-specific equipment, techniques, and chemicals, and 

(2) Patient demographics, including age, sex, and ethnicity.




Key Insights


Blood contains red blood cells (RBCs), white blood cells (WBCs), and platelets. RBCs transport oxygen via hemoglobin, WBCs defend against infections and maintain immune balance, and platelets prevent blood loss by forming clots and aiding tissue repair. 

Figure 1: Blood is divided into three parts: 55% is plasma, which comprises of water (93%), salts, proteins, lipids, and glucose; 45% are red blood cells; and 1% are WBCs and platelets. 



A WBC differential measures neutrophils, lymphocytes, monocytes, eosinophils, and basophils. Monocytes eliminate pathogens and provide key diagnostic insights into inflammatory conditions like infections, autoimmune disorders, and cancer. Lifestyle factors like diet, stress, and exercise influence monocyte levels and overall health.


What Are Basophils?


Basophils, the smallest WBCs (<1%), are 5–10 μm in size and release inflammatory mediators upon IgE binding.  Unlike other immune cells, they attack unfamiliar particles via phagocytosis. Identified by deep-purple granules, basophils interact with WBCs to fight pathogens and toxins. Like mast cells, they release histamine and heparin but adapt their response to inflammation. They aid WBC maturation, transport, and wound repair . Excessive activity can mislabel healthy tissues, triggering allergies and autoimmune diseases like diabetes, IBD, and asthma.


Basophils also regulate fat metabolism and energy balance. Their chemicals, including IL-4 and histamine, increase ROS, leading to oxidative stress, cell damage, and metabolic disruption. Excess ROS recruits immune cells for repair, but uncontrolled inflammation can harm tissues. Chronic inflammation reduces energy production, triggering a cascade of harmful reactions:

  1. Liver function: Increases glucose production, stores fats and proteins, and breaks down muscle while reducing fat metabolism.

  2. Glucose impact: Binds hemoglobin, lowers oxygen (hypoxia), triggers insulin, and increases glucose uptake.

  3. Hypoxia effects: Reduces energy, raises ROS, and increases tissue injury.

  4. Chronic inflammation: Damages organs, causes anemia, obesity, atherosclerosis, diabetes, fatty liver, muscle weakness, infertility, and cancer. Basophil dysregulation research has been limited since the 1980s .


Basophil Formation and Regulation 


All blood cells originate from hematopoietic stem cells (HSCs) in bone marrow, primarily in flat bones. HSCs differentiate into red blood cells, megakaryocytes (platelet precursors), and white blood cells . Myeloid progenitors (CMPs) develop into granulocyte-monocyte progenitors (GMPs), which form granulocytes like eosinophils, basophils, mast cells, and neutrophils. Specialized progenitors, including pre-BMPs and BMCPs, can differentiate into basophils or mast cells. Basophil progenitors (BaPs) in bone marrow become basophils, while mast cell progenitors (MCPs) in bone marrow, spleen, and tissues like the small intestine mature into mast cells after migration.

Figure 2: Basophils and mast cells develop from hematopoietic stem cells (HSCs) into multipotent, myeloid, and granulocyte-monocyte progenitors in bone marrow. Bipotential progenitors, including pre-BMPs and BMCPs, differentiate into basophil (BaPs) and mast cell progenitors (MCPs). MCPs mature into mast cells after migrating to tissues.



Reactive oxygen species (ROS), proinflammatory proteins, growth factors, and transcription factors regulate progenitor cell differentiation into basophils and mast cells14. 

  1. Cytokine Growth Factor Stem Cell Factor (SCF): SCF binds to the c-Kit receptor on progenitor cells and plays a vital role in the development, survival, and proliferation of mast cells from HSCs.

  2. Cytokine Interleukin-3 (IL-3) promotes the growth and differentiation of basophil precursors from common myeloid progenitors into mature basophils.

  3. GATA-binding proteins 1 and 2 Transcription Factors (GATA1, GATA-2) are critical regulators of activating genes involved in the differentiation of HSCs into basophils and mast cells.

  4. PU.1 Transcription Factor (PU.1) regulates gene expression that promotes basophil and mast cell differentiation.

  5. Cytokine Interleukin-5 (IL-5): Although primarily associated with eosinophil differentiation, IL-5 can also influence basophil development and function.


WBCs, bone marrow stromal, and endothelial cells produce signaling proteins. Endothelial cells release cytokines after injury, recruiting WBCs for repair. Dendritic cells present antigens and produce IL-4, promoting basophil and mast cell differentiation.

Basophils mature in bone marrow in seven days, circulate for 1–2 days, and rarely remain in tissues. During inflammation, they degranulate upon antigen-IgE binding, releasing histamine and heparin. Histamine widens blood vessels for immune access, while heparin prevents clotting, aiding repair. Basophils survive in tissues for days to weeks before apoptosis.

Basophils circulate in blood but concentrate in the lungs, gut, lymph nodes, spleen, and skin. The lungs oxygenate blood, and the gut supports digestion. Injury activates basophils to clear debris and repair tissues17 . In the spleen and lymph nodes, basophils regulate immune responses, hypersensitivity, inflammation, atherosclerosis, WBC production, and antibody synthesis.

Figure 3: Transcription factors and proinflammatory proteins regulate basophil production, circulation, and migration to tissues like the spleen, lungs, and skin. Activated basophils trigger allergic responses, aid Th2 and dendritic cell maturation, and protect against pathogens.


Clinical Significance of a High Basophil Count (Basophilia)


Basophilia occurs when basophils exceed 100/mm³ in blood,signaling inflammation from pathogens, allergens, or toxins. It can impair organs like the bone marrow, spleen, lungs, and gut and is linked to blood disorders like CML, polycythemia vera, myelofibrosis, and thrombocythemia. Excess ROS mutations disrupt protein production, leading to defective blood cells and severe health issues. 


Basophilia, often mild and asymptomatic, results from hypersensitivity to foods, drugs, toxins, or infections. It is usually detected through routine blood tests.


Those with basophilia typically are overweight to obese and have higher white blood cell counts and liver enzyme levels but lower lung function compared to those without basophilia. While basophilia itself doesn’t typically cause direct symptoms, it often indicates an underlying condition. The symptoms associated with basophilia depend on the affected organ(s):


  • Skin: Rash, swelling, itchiness.

  • Sinuses: Runny nose, watery eyes, congestion, headache.

  • Lungs: Breathing issues, cough, low blood pressure, chest pain, palpitations.

  • Heart/Vessels: Weakness, chronic fatigue.

  • Joints: Pain, stiffness.

  • Chronic Infection: Fever, night sweats, malaise.

  • Blood/Liver/Spleen: Easy bruising, abnormal bleeding.

  • Nervous System: Confusion, learning issues, vision/hearing trouble.

  • Digestive Tract: Throat pain, bloating, gut issues, weight changes.

           


Figure 4: Chronic basophilia, driven by excess proinflammatory proteins and ROS, triggers hypersensitivity responses that damage organs and microbiota. This immune overactivation mutates genes, disrupts cell function, and contributes to cardiovascular, lung, digestive, skin, and neurological diseases.



Basophilic disorders are diagnosed according to the location where the basophil count is elevated:

  • Blood Vessels: Basophilic vasculitis, atherosclerosis, clotting disorders, heart attack, emboli, aneurysm, stroke.

  • Bone Marrow: Basophilic leukemia, CML, polycythemia vera.

  • Lungs: Basophilic asthma, systemic mastocytosis, COPD.

  • Sinuses: Allergies, hay fever.

  • Gut: Basophilic enteropathy, IBD (Crohn’s, ulcerative colitis, celiac disease), food allergies.

  • Skin: Basophilic dermatitis, hives, allergic dermatitis, eczema.

  • Joints: Basophilic arthritis, rheumatoid arthritis.

Basophilia affecting multiple organs is often misdiagnosed, leading to unnecessary treatments like antibiotics. A biopsy confirms basophil presence in affected tissues. Without proper treatment, severe cases have an 80% mortality rate within two years, but tyrosine kinase inhibitors (TKIs) and lifestyle changes significantly improve survival. 


Basophilia-related deaths stem from organ complications, such as bone marrow failure in leukemia, causing anemia, infections, and bleeding disorders. Some cancer and autoimmune disease treatments can worsen basophilia, leading to severe health risks.


Basophilia is linked to dehydration and atherosclerosis, which reduce blood flow (vasoconstriction) and impair digestion. Vasoconstriction lowers stomach acid (HCl), disrupting gut microbiota and nutrient absorption, leading to undigested food particles triggering inflammation.18. Hypoxia reduces energy production and cell function, while rising reactive oxygen species (ROS) and toxic byproducts worsen inflammation.

Figure 5: Healthy gut microbiota support digestion, nutrient absorption, and waste excretion, maintaining metabolic balance. Dysbiosis disrupts these functions, increasing harmful pathogens and altering immune responses.


Oxidative stress oxidizes LDL cholesterol, which deposits in injured vessels to form a temporary plug. Reactive oxygen species (ROS) activate the reticuloendothelial system to release immune cells like eosinophils, clearing debris, preventing bleeding, and repairing wounds. Platelets and endothelial cells form clots, deposit plaque, and promote angiogenesis, driving oxidative stress-induced atherosclerosis.

 


Figure 6: Atherosclerosis thickens vessel walls with fat and scar tissue, forming clots to prevent bleeding. It restricts blood flow, raises pressure, and causes blood backup in organs. Hypoxia increases eosinophil infiltration and proinflammatory proteins, leading to chronic basophilic inflammation that damages organ structure and function .



A 2017 study published in the American Journal of Epidemiology demonstrated that a rising Eos count is associated with the progression of atherosclerosis-induced vascular diseases and shorter lifespan24 . Culprits responsible for causing tissue injury include ROS mutating genes involved in various metabolic processes and reducing cell division and differentiation. Basophils work hard to rebalance metabolism and control ROS levels and inflammation. 



Infections

One of the most common causes of basophilia is infections. Parasitic helminths, affecting 1.5 billion people in tropical regions, include roundworms (nematodes) and flatworms (trematodes, cestodes). Soil-transmitted helminths spread through contaminated soil, food, and water. During infection, T cells release proteins that recruit basophils and eosinophils to clear debris and repair tissue.Helminths evade immune responses, surviving in hosts for years. Persistent basophilia causes chronic inflammation, restricting blood flow, worsening dysbiosis, and activating dormant pathogens. Viruses then hijack cells, steal nutrients, and produce toxins that alter metabolism, increasing abnormal or cancerous cells.


                          

Figure 7: Viruses infect cells by binding to surface receptors and entering through injection or endocytosis. Inside, they hijack the host’s functions to replicate and produce new viruses, spreading the infection to neighboring cells. 

A 1994 study found 78% of chronic fatigue syndrome patients had markers of chronic viral infections like Epstein-Barr virus (EBV), with 50% showing elevated antibodies to HHV and HSV, often found in elderly brains. Viruses disrupt brain and organ function, contributing to learning disorders, mood disorders, and dementia linked to basophilia-induced inflammation30 . 

Studies estimate that 1 in 10 cancers stems from chronic atherosclerosis-induced inflammation and dysbiosis, disrupting basophil function and increasing viral infections (HIV, HSV, EBV, HHV), clotting, fibrosis, and organ damage. EBV, the first known cancer-causing virus, infects over 90% of people, often asymptomatically in childhood, and reactivates under stress, triggering inflammation, autoimmune disorders, and cancers .Chronic myeloid leukemia (CML), affecting about 30% of adult bone marrow disorders, involves dysregulated basophil production. CML incidence has slightly increased since 1990, occurring mostly in men over 20.

Figure 8: Chronic inflammation increases ROS, proinflammatory proteins, and oxidized cholesterol, activating leukocytes and platelets. This leads to tissue damage, clotting, plaque buildup, restricted blood flow, and high blood pressure. Untreated, it promotes infections, cancer, vascular diseases, autoimmune disorders, and organ failure.

Figure 9: Excess oxidized cholesterol, proinflammatory proteins, and ROS damage tissues, mutate genes, and impair cell function, while low nitric oxide weakens blood vessels. The immune system responds by embedding oxidized cholesterol into membranes and recruiting neutrophils. Tumor cells bind to arterial walls, activate platelets, promote clotting and new blood vessels, and evade destruction by NK cells. Proinflammatory proteins further fuel inflammation and cancer growth. 


Inflammatory Bowel Diseases

Inflammatory bowel diseases (IBD), including Crohn’s, celiac disease, ulcerative colitis, and food allergies, are autoimmune disorders causing basophilia. Triggers include dietary proteins like gluten in celiac disease. IBD incidence is 10.9 per 100,000 person-years, peaking in the third decade. In 2020, 2.39 million Americans had IBD, with higher rates among Caucasians and those of Mexican descent.


Active IBD features excess basophil, eosinophil, and lymphocyte infiltration in the small intestine, responding to harmful substances that threaten the intestinal barrier. IBD patients have high enzyme levels, signaling increased immune activity at injury sites. Undigested food, microbes, and allergens can breach the barrier, enter circulation, and damage organs and tissues.



Lung Diseases

In 2021, 14.2 million U.S. adults (6.5%) had Chronic Obstructive Lung Disease (COPD),with rates stable since 2011 and higher in rural areas due to smoking, aging, and socioeconomic challenges. About 25% of COPD patients (3.8 million) never smoked. COPD involves increased CD8+ T cells.Tobacco exposure and red blood cell destruction trigger atherosclerosis and basophils to release toxins, impairing oxygen delivery in lung capillaries24. During stress, megakaryocytes (MKs) escape bone marrow, migrate to low-oxygen lung areas, and convert to platelets . Heightened lung basophil activity facilitates pulmonary vasculature to convert MK to platelets—up to 10 million per hour in mice. Reduced blood flow fuels inflammation, promoting vascular disease and autoimmune disorders in the lungs, gut, bone marrow, and skin.


Figure 10: Low oxygen boosts red blood cell production, causing megakaryocytes (MKs) to escape bone marrow to the lungs. When oxygen rises, MKs convert to platelets and degrade quickly. Chronic inflammation accelerates platelet loss, reducing thrombopoietin and suppressing bone marrow platelet production.


Clinical Significance of Low Basophil Count (Basopenia)


Basopenia, a rare condition with low basophil counts (0.5–1% of WBCs),4 is difficult to detect but can be identified by flow cytometry. It occurs in chronic hypersensitivity reactions, autoimmune diseases like lupus, and after corticosteroid use. Chronic stress hormone overproduction, particularly cortisol, suppresses immune function, disrupts fat metabolism, and increases glucose production, leading to oxidative stress. This damages cells, alters metabolism, and weakens the reticuloendothelial system, reducing blood cell production and increasing the risk of organ failure and lower survival rates.

Chronic Hives (Urticaria)

Basopenia indicates the severity of chronic hives (urticaria), which causes skin wheals and angioedema4. Urticaria lasting over six weeks increases basophil migration to the skin, lowering blood levels. Basophil counts normalize when the root cause is treated.

Corticosteroids treat hives, eczema, and other skin conditions by suppressing basophil migration, temporarily raising blood levels but not improving immune health. They accelerate basophil death by 72% without reducing histamine sensitivity, leading to persistent WBC overactivation and increased total WBC count. 

Autoimmune Diseases 

Basopenia, linked to rising autoimmune diseases (3–5% of the U.S. population),results from dysbiosis, vasoconstriction, and dehydration, over activating the immune system. This disrupts digestion, nutrient absorption, and waste excretion, shifting WBCs from pathogen defense to tissue repair .


Atherosclerosis-induced vasoconstriction causes WBCs to attack healthy cells, triggering autoimmune diseases like lupus, diabetes, NAFLD, CVD, and bone marrow cancers, all marked by chronic inflammation and basopenia . 


Globally, SLE affects 5.14 per 100,000 annually, with 0.4 million new U.S. cases. Women have higher rates, and prevalence is highest in high-income countries like Poland, the U.S., and Barbados.


In 2015, 415 million adults had diabetes, 90% with type 2 (T2DM),24 and 55% of T2DM patients also had NAFLD. T1DM affects 15 per 100,000 in the U.S. and 9.5% globally. In 2021, 8.4 million had T1DM, with 500,000 new cases and 35,000 undiagnosed deaths.

Conclusion

Basophil count is a key marker of immune health, indicating risks for inflammation, poor circulation, dysbiosis, and hormonal imbalances. Basophilia increases proinflammatory proteins and ROS, damaging cells and mutating genes, while basopenia is linked to chronic inflammation, vascular diseases, autoimmune disorders, infections, and cancer. Symptoms vary, making diagnosis challenging. Poor nutrition, stress, and sleep issues disrupt blood flow, digestion, and metabolism. Managing basophil levels requires lifestyle changes, diet, exercise, hydration, and reduced medication use. A multidisciplinary approach can restore balance, improve health, and lower disease risks.


Source References and Supplemental Research:

  1.  Young B, Lowe jo, Stevens A, Heath JW (2006). Wheater’s Functional Histology (5th ed.). Elsevier Limited. ISBN 978-0-443-06850-8.

  2. Dean L. Blood Groups and Red Cell Antigens [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2005. Chapter 1, Blood and the cells it contains. Available from: [PubMed] 

  3.  Chirumbolo S, Bjørklund G, Sboarina A, Vella A. The role of basophils as innate immune regulatory cells in allergy and immunotherapy. Hum Vaccin Immunother. 2018;14(4):815-831. doi:10.1080/21645515.2017.1417711 [PubMed] [PMC Full Text] [Crosslink]

  4.  Shah H, Eisenbarth S, Tormey CA, Siddon AJ. Behind the scenes with basophils: an emerging therapeutic target. Immunother Adv. 2021;1(1):ltab008. Published 2021 May 19. doi:10.1093/immadv/ltab008 [[PubMed] [PMC Full Text] [Crosslink]

  5.  Miyake K, Ito J, Karasuyama H. Role of Basophils in a Broad Spectrum of Disorders. Front Immunol. 2022;13:902494. Published 2022 May 27. doi:10.3389/fimmu.2022.902494 [PubMed] [PMC Full Text] [Crosslink]

  6.  Zhang N, Zhang Z-M, Wang X-F. The roles of basophils in mediating the immune responses. Eur J Inflamm. 2021;19:205873922110476. doi:10.1177/20587392211047644 [Crosslink]

  7.  Aoki A, Hirahara K, Kiuchi M, Nakayama T. Eosinophils: Cells known for over 140 years with broad and new functions. Allergology International. 2021;70(1):3-8. doi:10.1016/j.alit.2020.09.002 [Crosslink]

  8.  Diny N. L., Rose N. R., and Čiháková D., Eosinophils in autoimmune diseases, Frontiers in Immunology. (2017) 8, article no. 484, 2-s2.0-85018409319, https://doi.org/10.3389/fimmu.2017.00484. [Web of Science®] [Google Scholar]

  9.  Lee J. J., Jacobsen E. A., McGarry M. P., Schleimer R. P., and Lee N. A., Eosinophils in health and disease: the LIAR hypothesis, Clinical & Experimental Allergy. (2010) 40, no. 4, 563–575, https://doi.org/10.1111/j.1365-2222.2010.03484.x, 2-s2.0-77949349992. [PubMed] [Google Scholar]

  10.  Shi H.-Z., Humbles A., Gerard C., Jin Z., and Weller P. F., Lymph node trafficking and antigen presentation by endobronchial eosinophils, The Journal of Clinical Investigation. (2000) 105, no. 7, 945–953, 2-s2.0-0034086376, https://doi.org/10.1172/JCI8945. [CAS] [PubMed] [Google Scholar]

  11.  May ME , Waddell CC. Basophils in peripheral blood and bone marrow. A retrospective review. Am J Med1984;76:509–11.[Google Scholar] [Crossref] [PubMed]

  12.  Xu W , Wu HF, Ma SGet al.  Correlation between peripheral white blood cell counts and hyperglycemic emergencies. Int J Med Sci2013;10:758–65. [Google Scholar] [Crossref] [PubMed]

  13.  Grinenko T, Eugster A, Thielecke L, et al. Hematopoietic stem cells can differentiate into restricted myeloid progenitors before cell division in mice. Nat Commun. 2018;9(1):1898. Published 2018 May 15. doi:10.1038/s41467-018-04188-7 [PMC Full Text] [PubMed] [Crosslink] 

  14.  Sasaki H, Kurotaki D, Tamura T. Regulation of basophil and mast cell development by transcription factors. Allergol Int. 2016;65(2):127-134. doi:10.1016/j.alit.2016.01.006 [PubMed] [Crosslink]

  15.  Ohnmacht C, Voehringer D. Basophil effector function and homeostasis during helminth infection. Blood. 2009;113:2816–25. [PubMed] [Google Scholar]

  16.  Korošec P, Gibbs BF, Rijavec M, Custovic A, Turner PJ. Important and specific role for basophils in acute allergic reactions. Clin Exp Allergy. 2018 May;48(5):502-512. [PMC free article] [PubMed]

  17.  Min B, Brown MA, Legros G. Understanding the roles of basophils: breaking dawn. Immunology. 2012;135(3):192-197. doi:10.1111/j.1365-2567.2011.03530.x. [PubMed]

  18.  What Is Gut Dysbiosis? Cleveland Clinic. [Cleveland Clinic] 

  19.  Sticco KL, Pandya NK, Zubair M, et al. Basophilia. [Updated 2024 Aug 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535365/.

  20.  Sreedharanunni S, Kumar N, Prakash G. Basophilia and megakaryoblastic differentiation in a case of acute myeloid leukemia: An unusual morphological combination. Hematol Oncol Stem Cell Ther. 2016;9(1):30-33. doi:10.1016/j.hemonc.2015.06.003 [PubMed] [Crosslink]

  21.  M. C. Siracusa, B. S. Kim, J. M. Spergel, and D. Artis, “Basophils and allergic inflammation,” Journal of Allergy and Clinical Immunology, vol. 132, no. 4, pp. 789–801, 2013. doi:10.1016/j.jaci.2013.07.046 [PubMed]

  22.  Papadakis S, Liapis I, Papadhimitriou SI, Spanoudakis E, Kotsianidis I, Liapis K. Approach to Acute Myeloid Leukemia with Increased Eosinophils and Basophils. Journal of Clinical Medicine. 2024; 13(3):876. https://doi.org/10.3390/jcm13030876. [MDPI]

  23.  Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011;12:204–12. [PubMed] [Crosslink]. 

  24.  Herrero-Cervera, A., Soehnlein, O. & Kenne, E. Neutrophils in chronic inflammatory diseases. Cell Mol Immunol. 2022;19(2):177-191. doi:10.1038/s41423-021-00832-3 [PubMed] [PMC Full Text] [Crosslink]

  25.  Nordestgaard, B. G., & Varbo, A. (2014). Triglycerides and cardiovascular disease. The Lancet, 384(9943), 626–635. https://doi.org/10.1016/s0140-6736(14)61177-6 [Science Direct] [Scopus] [Google Scholar] 

  26.  Varbo, A., Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2013). Elevated remnant cholesterol causes both Low-Grade inflammation and ischemic heart disease, whereas elevated Low-Density lipoprotein cholesterol causes ischemic heart disease without inflammation. Circulation, 128(12), 1298–1309. https://doi.org/10.1161/circulationaha.113.003008 [Scopus] [Google Scholar]

  27.  Silvestre-Roig C, Braster Q, Ortega-Gomez A, Soehnlein O. Neutrophils as regulators of cardiovascular inflammation. Nat Rev Cardiol. 2020;17:327–40. [PubMed] [Crosslink]. 

  28.  Soehnlein O, Steffens S, Hidalgo A, Weber C. Neutrophils as protagonists and targets in chronic inflammation. Nat Rev Immunol. 2017;17:248–61. [PubMed] [Crosslink]. 

  29.  Soehnlein O, Libby P. Targeting inflammation in atherosclerosis — from experimental insights to the clinic. Nat Rev Drug Discov. 2021;20:589–610. [PubMed]. 

  30.  Kabat GC, Kim MY, Manson JE, et al. White Blood Cell Count and Total and Cause-Specific Mortality in the Women’s Health Initiative. Am J Epidemiol. 2017;186(1):63-72. doi:10.1093/aje/kww226. [PubMed] 

  31.  Martviset P, Phadungsil W, Na-Bangchang K, et al. Current prevalence and geographic distribution of helminth infections in the parasitic endemic areas of rural Northeastern Thailand. BMC Public Health. 2023;23(1):448. Published 2023 Mar 8. doi:10.1186/s12889-023-15378-4 [PubMed] [PMC Full Text] [Crosslink]

  32.  Shin MH, Lee YA, Min DY. Eosinophil-mediated tissue inflammatory responses in helminth infection. Korean J Parasitol. 2009;47 Suppl(Suppl):S125-S131. doi:10.3347/kjp.2009.47.S.S125 [PubMed] [PMC Full Text] [Crosslink]

  33.  Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th edition. New York: Garland Science; 2002. Cell Biology of Infection. Available from: [PubMed] 

  34.  Hilgers A, Frank J. Chronic Fatigue Syndrome: immune dysfunction, role of pathogens and toxic agents and neurological and cardiac changes. Wien Med Wochenschr. 1994;144(16):399-406. [Pubmed]

  35.  Wang Y, Ding L, Zhu Q, Shu M, Cai Q. Common Infections May Lead to Alzheimer’s Disease. Virol Sin. 2018;33(5):456-458. doi:10.1007/s12250-018-0049-7 [Pubmed] [Springer]

  36.  Pyzik A, Grywalska E, Matyjaszek-Matuszek B, et al. Does the Epstein-Barr Virus Play a Role in the Pathogenesis of Graves’ Disease?. Int J Mol Sci. 2019;20(13):3145. Published 2019 Jun 27. doi:10.3390/ijms20133145 [Pubmed] [MDPI] [PMC]

  37.  Alizon S, Bravo IG, Farrell PJ, Roberts S. Towards a multi-level and a multi-disciplinary approach to DNA oncovirus virulence. Philos Trans R Soc Lond B Biol Sci. 2019;374(1773):20190041. doi:10.1098/rstb.2019.0041 [Pubmed] [The Royal Society] [PMC]

  38.  Yu H, Robertson ES. Epstein-Barr Virus History and Pathogenesis. Viruses. 2023;15(3):714. Published 2023 Mar 9. doi:10.3390/v15030714 [PubMed] [PMC Full Text] [Crosslink]

  39.  Smatti MK, Al-Sadeq DW, Ali NH, Pintus G, Abou-Saleh H, Nasrallah GK. Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update. Front Oncol. 2018;8:211. Published 2018 Jun 13. doi:10.3389/fonc.2018.00211 [PubMed] [PMC Full Text] [Crosslink]

  40.  Lin J, Chen X, Wu H, Chen X, Hu X, Xu J. Peripheral blood lymphocyte counts in patients with infectious mononucleosis or chronic active Epstein-Barr virus infection and prognostic risk factors of chronic active Epstein-Barr virus infection. Am J Transl Res. 2021;13(11):12797-12806. Published 2021 Nov 15. [PubMed] [PMC Full Text]

  41.  Lin Q, Mao L, Shao L, et al. Global, Regional, and National Burden of Chronic Myeloid Leukemia, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Front Oncol. 2020;10:580759. Published 2020 Dec 15. doi:10.3389/fonc.2020.580759 [PubMed] [PMC Full Text] [Crosslink]

  42.  McDowell C, Farooq U, Haseeb M. Inflammatory Bowel Disease. [Updated 2023 Aug 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470312/

  43.  Lewis JD, Parlett LE, Jonsson Funk ML, et al. Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States. Gastroenterology. 2023;165(5):1197-1205.e2. doi:10.1053/j.gastro.2023.07.003 [PubMed] [Crosslink]

  44.  Gomez-Bris R, Saez A, Herrero-Fernandez B, Rius C, Sanchez-Martinez H, Gonzalez-Granado JM. CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease. International Journal of Molecular Sciences. 2023; 24(3):2696. https://doi.org/10.3390/ijms24032696. [MDPI]

  45.  Nikolakis D, de Voogd FAE, Pruijt MJ, Grootjans J, van de Sande MG, D’Haens GR. The Role of the Lymphatic System in the Pathogenesis and Treatment of Inflammatory Bowel Disease. International Journal of Molecular Sciences. 2022; 23(3):1854. https://doi.org/10.3390/ijms23031854. [MDPI]

  46.  Liu Y, Carlson SA, Watson KB, Xu F, Greenlund KJ. Trends in the Prevalence of Chronic Obstructive Pulmonary Disease Among Adults Aged ≥18 Years — United States, 2011–2021. MMWR Morb Mortal Wkly Rep 2023;72:1250–1256. DOI: http://dx.doi.org/10.15585/mmwr.mm7246a1.

  47.  Williams, M., Todd, I. & Fairclough, L.C. The role of CD8 + T lymphocytes in chronic obstructive pulmonary disease: a systematic review. Inflamm. Res. 70, 11–18 (2021). https://doi.org/10.1007/s00011-020-01408-z. [SpringerLink]

  48.  Zhao. Platelet generation from circulating megakaryocytes is triggered in the lung vasculature. BioRXiv (2021) bioRxiv 2021.11.01.466743. doi: 10.21203/rs.3.rs-690639/v1 [BioRXiv Full Text] [Crosslink] 

  49.  Gelon L, Fromont L, Lefrançais E. Occurrence and role of lung megakaryocytes in infection and inflammation. Frontiers in Immunology. 2022;13. doi:10.3389/fimmu.2022.1029223 [PubMed] [PMC Full Text] [Crosslink]

  50.  Lefrançais, E., Ortiz-Muñoz, G., Caudrillier, A. et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature 544, 105–109 (2017). https://doi.org/10.1038/nature21706. [Nature]. [NIH].

  51.  Sebastian, S., Lucey, B.C. (2008). Reticuloendothelium Malignancy: Current Role of Imaging. In: Blake, M.A., Kalra, M.K. (eds) Imaging in Oncology. Cancer Treatment and Research, vol 143. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-75587-8_17. [SpringerLink]

  52.  Saini SS. Urticaria and basophils. Allergology International. 2023;72(3):369-374. doi:10.1016/j.alit.2023.05.001 [Elsevier]

  53.  Grattan CE , Dawn G, Gibbs Set al.  Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin Exp Allergy2003;33:337–41.[Google Scholar][Crossref] [PubMed]

  54.  Dunsky EH , Zweiman B, Fischler Eet al.  Early effects of corticosteroids on basophils, leukocyte histamine, and tissue histamine. J Allergy Clin Immunol1979;63:426–32.[Google Scholar][PubMed]

  55.  Wang L, Wang FS, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. 2015;278:369–95. [PubMed] [Crosslink]. 

  56.  Dasagrandhi, D., Muthuswamy, A. & Swaminathan, J.K. Atherosclerosis: nexus of vascular dynamics and cellular cross talks. Mol Cell Biochem 477, 571–584 (2022). https://doi.org/10.1007/s11010-021-04307-x. [SpringerLink]

  57.  Mandy O J Grootaert, Martin R Bennett, Vascular smooth muscle cells in atherosclerosis: time for a re-assessment, Cardiovascular Research, Volume 117, Issue 11, 1 October 2021, Pages 2326–2339, https://doi.org/10.1093/cvr/cvab046. [Oxford Academic]

  58.  Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88–98. [PubMed] [Crosslink].

  59.  Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The diabetes mellitus–atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci. 2020;21:1835. [PMC Full Text] [Crosslink]. 

  60.  Tian J, Zhang D, Yao X, Huang Y, Lu Q. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis. 2023;82(3):351-356. doi:10.1136/ard-2022-223035 [PubMed] [PMC Full Text] [Crosslink]

  61.  Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect. 2020;10(2):98-115. Published 2020 Mar 30. doi:10.34172/hpp.2020.18 [PubMed] [PMC Full Text] [Crosslink]

  62.  Gregory GA, Robinson TIG, Linklater SE, et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modeling study [published correction appears in Lancet Diabetes Endocrinol. 2022 Nov;10(11):e11. doi: 10.1016/S2213-8587(22)00280-7]. Lancet Diabetes Endocrinol. 2022;10(10):741-760. doi:10.1016/S2213-8587(22)00218-2 [PubMed] [Crosslink]

  63.  Yen Jean MC, Hsu CC, Hung WC, et al. Association between lifestyle and hematological parameters: A study of Chinese male steelworkers. J Clin Lab Anal. 2019;33(7):e22946. doi:10.1002/jcla.22946 [PubMed] [PMC Full Text] [Crosslink]

  64.  Wirth MD, Sevoyan M, Hofseth L, Shivappa N, Hurley TG, Hébert JR. The Dietary Inflammatory Index is associated with elevated white blood cell counts in the National Health and Nutrition Examination Survey. Brain Behav Immun. 2018;69:296-303. doi:10.1016/j.bbi.2017.12.003 [PubMed] [PMC Full Text] [Crosslink]

  65.  Cedars-Sinai Staff. Are animal proteins better for you than plant proteins? Cedars Sinai. January 16, 2019. Accessed September 2, 2024. [Website] 

  66.  Koenig G, Seneff S. Gamma-glutamyltransferase: A predictive biomarker of cellular antioxidant inadequacy and disease risk. Dis Markers. 2015:2015:818570. PMID: 26543300. doi: 10.1155/2015/818570. [PubMed] [Wiley] [PubMed]

  67.  De Chiara, F., Checcllo, C. U., & Azcón, J. R. (2019). High protein diet and metabolic plasticity in Non-Alcoholic Fatty liver Disease: Myths and Truths. Nutrients, 11(12), 2985. https://doi.org/10.3390/nu11122985 [PubMed] 

  68.  Balkaransingh PD, Wheeler D, Ning Y, Helou MA, Massey G. Dietary determinants of the White Blood Cell Count. Blood. 2013;122(21):1705-1705. doi:10.1182/blood.v122.21.1705.1705 [Crosslink] [Full Text]

  69.  Guoyao Wu; Yun-Zhong Fang; Sheng Yang; Joanne R. Lupton; Nancy D. Turner (2004). “Glutathione Metabolism and its Implications for Health”. Journal of Nutrition. 134 (3): 489–492. doi:10.1093/jn/134.3.489. PMID 14988435 [PubMed] [Crosslink] 

  70.  Ho, P.I.; Ortiz, D.; Rogers, E.; Shea, T.B. Multiple aspects of homocysteine neurotoxicity: Glutamate excitotoxicity, kinase hyperactivation and DNA damage. J. Neurosci. Res. 2002, 70, 694–702. [Google Scholar] [CrossRef] [PubMed]

  71.  Menni C, Louca P, Berry SE, et al. High intake of vegetables is linked to lower white blood cell profile and the effect is mediated by the gut microbiome. BMC Med. 2021;19(1):37. Published 2021 Feb 11. doi:10.1186/s12916-021-01913-w [PubMed] [PMC Full Text] [Crosslink]

  72.  Hernáez Á, Lassale C, Castro-Barquero S, Babio N, Ros E, Castañer O, Tresserra-Rimbau A, Pintó X, Martínez-González MÁ, Corella D, et al. Mediterranean Diet and White Blood Cell Count—A Randomized Controlled Trial. Foods. 2021; 10(6):1268. https://doi.org/10.3390/foods10061268. [MDPII]

  73.  Moll S, Varga EA. Homocysteine and MTHFR Mutations. Circulation. 2015;132(1). doi:https://doi.org/10.1161/circulationaha.114.013311 [AHA Journals] [Crosslink] 

  74.  Esse, R.; Barroso, M.; Almeida, I.; Castro, R. The contribution of homocysteine metabolism disruption to endothelial dysfunction: State-of-the-art. Int. J. Mol. Sci. 2019, 20, 867. [Google Scholar] [CrossRef] [Green Version]. 

  75.  Kruman, I.I.; Culmsee, C.; Chan, S.L.; Kruman, Y.; Guo, Z.; Penix, L.; Mattson, M.P. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci. 2000, 20, 6920–6926. [PubMed]

  76.  Ho, P.I.; Ashline, D.; Dhitavat, S.; Ortiz, D.; Collins, S.C.; Shea, T.B.; Rogers, E. Folate deprivation induces neurodegeneration: Roles of oxidative stress and increased homocysteine. Neurobiol. Dis. 2003, 14, 32–42. [PubMed]

  77.  Piskin E, Cianciosi D,  Gulec S, Tomas M, Capanoglu E. Iron Absorption: Factors, Limitations, and Improvement Methods. ACS Omega. 2022 Jun 21; 7(24): 20441–20456. doi: 10.1021/acsomega.2c01833 [PMC] [Crosslink] 

  78.  Boldt D. H. New Perspectives on Iron: An Introduction. Am. J. Med. Sci. 1999, 318 (4), 207. 10.1097/00000441-199910000-00001. [PubMed]

  79.  Smirnoff N. Ascorbic Acid Metabolism and Functions: A Comparison of Plants and Mammals. Free Radic. Biol. Med. 2018, 122, 116–129. 10.1016/j.freeradbiomed.2018.03.033. [PubMed]

  80.  Benkhedda K.; L’abbé M. R.; Cockell K. A. Effect of Calcium on Iron Absorption in Women with Marginal Iron Status. Br. J. Nutr. 2010, 103 (5), 742–748. 10.1017/S0007114509992418. [PubMed] [Cambridge Core]

  81.  Ziegler E.E. Consumption of cow’s milk as a cause of iron deficiency in infants and toddlers. Nutr. Rev. 2011;69:37–42. doi: 10.1111/j.1753-4887.2011.00431.x. [PubMed] [Oxford Academic]

  82.  Cory H, Passarelli S, Szeto J, Tamez M, Mattei J. The Role of Polyphenols in Human Health and Food Systems: A Mini-Review. Front Nutr. 2018;5:87. Published 2018 Sep 21. doi:10.3389/fnut.2018.00087 [PubMed]

  83. Zhang H, Tsao R. Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory effects. Curr Opin Food Sci. (2016) 8:33–42. 10.1016/j.cofs.2016.02.002 [CrossRef] [Google Scholar]

  84.  Hart J. J.; Tako E.; Kochian L. V.; Glahn R. P. Identification of Black Bean (Phaseolus Vulgaris L.) Polyphenols That Inhibit and Promote Iron Uptake by Caco-2 Cells. J. Agric. Food Chem. 2015, 63 (25), 5950–5956. 10.1021/acs.jafc.5b00531. [PubMed]

  85.  Naghedi-Baghdar, H., Nematy, M., Kooshyar, M. M., Taghipour, A., Sajadi Tabassi, S. A., Shokri, S., Javan, R., & Nazari, S. M. (2018). Effect of a functional food (vegetable soup) on blood rheology in patients with polycythemia. Avicenna journal of phytomedicine, 8(5), 389–398. [PubMed]

  86. Watso, J. C., & Farquhar, W. B. (2019). Hydration Status and Cardiovascular Function. Nutrients, 11(8), 1866. https://doi.org/10.3390/nu11081866 [PubMed]

  87. Popkin BM, D’Anci KE, Rosenberg IH. Water, hydration, and health. Nutr Rev. 2010;68(8):439-458. doi:10.1111/j.1753-4887.2010.00304.x [PubMed]

  88. Billett HH. Hemoglobin and Hematocrit. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990. Chapter 151. Available from: [PubMed] 

  89. Kennedy M. How much water you’re actually supposed to drink each day – and why 8 cups isn’t right for everyone. Business Insider. December 14, 2021. [Website] 

  90.  Pałka T, Koteja PM, Tota Ł, et al. The Influence of Various Hydration Strategies (Isotonic, Water, and No Hydration) on Hematological Indices, Plasma Volume, and Lactate Concentration in Young Men during Prolonged Cycling in Elevated Ambient Temperatures. Biology (Basel). 2023;12(5):687. Published 2023 May 7. doi:10.3390/biology12050687 [PubMed] [PMC Full Text] [Crosslink]

  91.  Ballard H. S. (1997). The hematological complications of alcoholism. Alcohol health and research world, 21(1), 42–52. [PubMed]

  92.  Bradley CS, Erickson BA, Messersmith EE, et al. Evidence of the Impact of Diet, Fluid Intake, Caffeine, Alcohol and Tobacco on Lower Urinary Tract Symptoms: A Systematic Review. J Urol. 2017;198(5):1010-1020. doi:10.1016/j.juro.2017.04.097 [PubMed] [PMC Full Text] [Full Text]

  93.  Polhuis KCMM, Wijnen AHC, Sierksma A, Calame W, Tieland M. The Diuretic Action of Weak and Strong Alcoholic Beverages in Elderly Men: A Randomized Diet-Controlled Crossover Trial. Nutrients. 2017;9(7):660. Published 2017 Jun 28. doi:10.3390/nu9070660 [PubMed]

  94.  Chung PS, Tsai KZ, Lin YP, Lin YK, Lin GM. Association between Leukocyte Counts and Physical Fitness in Male Military Members: The CHIEF Study. Sci Rep. 2020;10(1):6082. Published 2020 Apr 8. doi:10.1038/s41598-020-63147-9 [PubMed] [PMC Full Text] [Crosslink]

  95.  Johannsen NM, Swift DL, Johnson WD, et al. Effect of different doses of aerobic exercise on total white blood cell (WBC) and WBC subfraction number in postmenopausal women: results from DREW. PLoS One. 2012;7(2):e31319. doi:10.1371/journal.pone.0031319 [PubMed] [PMC Full Text] [Crosslink]

  96.  El-Sayed M. S. (1998). Effects of exercise and training on blood rheology. Sports medicine (Auckland, N.Z.), 26(5), 281–292. https://doi.org/10.2165/00007256-199826050-00001 [PubMed] [Springer]

  97.  Kilic-Toprak, E., Ardic, F., Erken, G., Unver-Kocak, F., Kucukatay, V., & Bor-Kucukatay, M. (2012). Hemorheological responses to progressive resistance exercise training in healthy young males. Medical science monitor : international medical journal of experimental and clinical research, 18(6), CR351–CR360. https://doi.org/10.12659/msm.882878 [PubMed] [ISI] [PubMed]

  98.  Kamal A, Malik RN. Hematological Evidence of Occupational Exposure to Chemicals and Other Factors among Auto-Repair Workers in Rawalpindi, Pakistan. Osong Public Health Res Perspect. 2012;3(4):229-238. doi:10.1016/j.phrp.2012.10.003 [PubMed]

  99.  Premont RT, Reynolds JD, Zhang R, Stamler JS. Role of Nitric Oxide Carried by Hemoglobin in Cardiovascular Physiology: Developments on a Three-Gas Respiratory Cycle. Circ Res. 2020;126(1):129-158. doi:10.1161/CIRCRESAHA.119.315626 [PubMed] [PMC Full Text] [Circulation Research]

  100.  Pedersen KM, Çolak Y, Ellervik C, Hasselbalch HC, Bojesen SE, Nordestgaard BG. Smoking and Increased White and Red Blood Cells. Arterioscler Thromb Vasc Biol. 2019;39(5):965-977. doi:10.1161/ATVBAHA.118.312338 [PubMed] [Crosslink]

  101.  Carel RS, Eviatar J. Factors affecting leukocyte count in healthy adults. Prev Med. 1985;14(5):607-619. doi:10.1016/0091-7435(85)90081-7 [PubMed] [Crosslink] 

  102.  Pillai AA, Fazal S, Mukkamalla SKR, Babiker HM. Polycythemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; May 20, 2023. [PubMed]

  103.  Lewandowska AM, Rudzki M, Rudzki S, Lewandowski T, Laskowska B. Environmental risk factors for cancer – review paper. Ann Agric Environ Med. 2019;26(1):1-7. doi:10.26444/aaem/94299 [PubMed] [Full Text]